Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-02-17Clinical Trial Update: Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL [Phase 2, Phase 3]
The trial studying dasatinib in imatinib-resistant or intolerant chronic myeloid leukemia or Philadelphia chromosome‑positive acute lymphobl…
-
CLINICAL_TRIALS withdrawal · 2015-10-30Clinical Trial Update: Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 study evaluating Nilotinib with combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic …
-
CLINICAL_TRIALS withdrawal · 2015-08-31Clinical Trial Update: A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies [Phase 1]
A Phase I study of an alloreactive cell infusion following transplantation of haplotype cells in patients with myeloid malignancies has been…
-
CLINICAL_TRIALS withdrawal · 2015-05-13Clinical Trial Update: An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase) [Phase 2]
Phase 2 open-label PK study of intramuscular Erwinaze (asparaginase Erwinia chrysanthemi) / Erwinase (crisantaspase) for acute lymphoblastic…
-
CLINICAL_TRIALS withdrawal · 2014-08-22Clinical Trial Update: Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia
A clinical trial investigating cardiometabolic status in childhood acute lymphoblastic leukemia has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-01-06Clinical Trial Update: IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL) [Phase 2]
Clinical trial update notes that the Phase 2 study of idelalisib (IPI-145) in relapsed/refractory acute lymphoblastic leukemia has been with…
-
CLINICAL_TRIALS withdrawal · 2013-12-03Clinical Trial Update: Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL) [Phase 1]
A Phase 1 trial evaluating sirolimus with PEG-asparaginase for acute lymphoblastic leukemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-06-12Clinical Trial Update: Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting [NA]
A pediatric clinical trial evaluating acupuncture point stimulation to prevent chemotherapy-induced nausea and vomiting has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-05-20Clinical Trial Update: Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Oncaspar and three doses of pegylated recombinant asparaginase in adults with newly diagnosed acute lymphoblast…
-
CLINICAL_TRIALS withdrawal · 2012-11-08Clinical Trial Update: Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL) [Phase 2]
A Phase 2 trial evaluating bendamustine for acute lymphoblastic leukemia and lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-09Clinical Trial Update: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant [NA]
A clinical trial evaluating mechanical stimulation to prevent bone density loss in patients undergoing donor stem cell transplant has been w…
-
CLINICAL_TRIALS withdrawal · 2012-03-23Clinical Trial Update: Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia [Phase 3]
A Phase 3 trial evaluating strategies to prevent CNS disease in children with acute lymphoblastic leukemia—radiation therapy to the head ver…